Hakim Anat, of Eli Lilly and Company (NYSE:LLY), sold 5,000 shares of company stock on November 02, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
At publication ·
Eli Lilly and Company (NYSE:LLY) · insider sell
At a glance
Hakim Anat, of Eli Lilly and Company (NYSE:LLY), sold 5,000 shares of company stock on November 02, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The shares were sold at an average price of $1402.52 per share, for a total transaction value of $7.0M. Following this transaction, Hakim Anat still owns 4,137 shares of Eli Lilly and Company stock.
Eli Lilly and Company's stock currently trades at $1417.72, giving the company a market capitalization of $906.5B.
Insider sales are common and don't necessarily indicate a bearish outlook. Executives regularly sell shares for tax planning, diversification, or personal liquidity. The key factors to watch are the size of the sale relative to the insider's total holdings, whether multiple insiders are selling simultaneously, and whether the trades occur near earnings announcements or other catalysts.
At $7.0 million, this transaction stands out as a significant commitment. Trades of this size from corporate insiders typically attract attention from institutional investors and analysts who track Form 4 filings for early signals about company direction.
Insider transaction data is reported to the SEC via Form 4 filings, typically within two business days of the trade. Investors can track insider activity alongside other metrics — such as institutional flows, short interest, and technical indicators — to build a more complete picture of market sentiment around Eli Lilly and Company.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 02, 2026 | Skovronsky Daniel | Sell | 119 | |
| Nov 02, 2026 | Hakim Anat | Sell | 5,000 | $7.0 million |
| Nov 01, 2026 | Brown Adrienne S | Sell | 2,530 | |
| Nov 01, 2026 | Brown Adrienne S | Sell | 1,099 | $1.6 million |
| Nov 01, 2026 | Brown Adrienne S | Buy | 2,530 |
Related Tools: Insider Trades Tracker | View LLY Stock Page
Insider insider_sells at Eli Lilly and Company (NYSE:LLY) are reported to the SEC via Form 4 filings. While a single transaction doesn't predict future stock performance, patterns of insider buying can signal management confidence.
Monitor all insider transactions on the LLY insider trades page or the Insider Trades Tracker.
Current market data
NYSE · LLY
$1,417.99
Down: -$41.59 · -2.93%
Live quote updated
Keep reading
institutional ·
insider ·
price ·
price ·
